Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).

Inclusion Criteria: * Age: 18 to 40 years * Body weight: ≥ 50 kg * BMI: 18.0 to 25.0 kg/m2 * Health: Generally healthy, with no clinically significant illnesses or surgeries in the past 12 weeks * Willingness to comply with trial procedures and restrictions Exclusion Criteria: * Significant current or recurrent disease * Acute significant disease or illness within 7 days before the start of the trial * Clinically significant deviations in blood tests * An estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73m2 * Positive test for alcohol, drugs of abuse, hepatitis B surface antigen (HBsAg), hepatitis C antibody (HCV Ab), or human immunodeficiency virus antibody (HIV Ab) * Pregnant or breastfeeding women * History or regular use of tobacco or other nicotine-containing products within 6 months before the start of the trial * Treatment with an investigational drug within 90 days or 5 half-lives (whichever is longer) or exposure to more than 3 investigational drugs within 12 months of first study drug administration * Use of prescription medication (excluding female hormonal contraception or hormone replacement therapy)within 30 days or 5 half * lives (whichever is longer) prior to first study drug administration, or use of over-the-counter (OTC) medication (including multivitamin, herbal, or homeopathic preparations; Paracetamol use ≤2g per day is permitted) during the 14 days or 5 half-lives of the drug (whichever is longer) before first study drug administ…